glp 1 drugs novo nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo, Lilly buoyed by fast-growing

While Golo Release is marketed as safe for most people, potential users should be cautious

Based on VigiBase, the World Health Organizations (WHO) adverse drug reaction database, intestinal obstructions are reported over 4.5 times more frequently with incretin-based drugs than with other diabetes medications [10]

Engineering supramolecular nanofiber depots from a glucagon-like peptide-1 therapeutic

Abstract Background Glucagon-like peptide-1 receptor agonists, originally developed for managing type 2 diabetes, have gained attention for their weight-reducing and broader biological effects

A core gut microbiome in obese and lean twins

Are they safe for elderly patients